Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Breast Neoplasms 11Leukemia, Myeloid, Acute 9Congenital Abnormalities 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Multiple Myeloma 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Colorectal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Burkitt Lymphoma 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Lung Neoplasms 4Leukemia, Myeloid, Accelerated Phase 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Blast Crisis 4Sezary Syndrome 3

Interventions

Dexamethasone 111Cyclophosphamide 99Melphalan 91Bortezomib 69Peripheral Blood Stem Cell Transplantation 64Lenalidomide 58fludarabine phosphate 56Busulfan 54Filgrastim 50Tacrolimus 38Antilymphocyte Serum 38Thalidomide 36Radiotherapy 36Mycophenolic Acid 33fludarabine 28Cyclosporine 26Methotrexate 25Etoposide 22Calcium Dobesilate 22Whole-Body Irradiation 21Prednisone 21Methylprednisolone 20sargramostim 19pomalidomide 19Granulocyte Colony-Stimulating Factor 18carfilzomib 16daratumumab 15Cord Blood Stem Cell Transplantation 15Carmustine 14Rituximab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × In Situ Hybridization, Fluorescence × Clear all
NCT00792142 2021-08-19

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

City of Hope Medical Center

Phase 2 Completed
45 enrolled 8 charts
Plasma cell

Multiple Myeloma, Neurotoxicity Syndromes, Neoplasms, Plasma Cell

NCT00898066 2015-03-06

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

SWOG Cancer Research Network

Completed
37 enrolled
LymphoidOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Lymphoma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡